Neil Kumar
Chief Executive Officer
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $1,044,000 | $14,944,585 |
| 2024 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $987,539 | $15,581,923 |
| 2023 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $742,000 | $12,158,626 |
| 2022 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $1,106,000 | $6,674,437 |
| 2021 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $725,000 | $25,626,959 |
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $550,000 | $10,054,909 |
| 2019 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $502,765 | $26,334,063 |
| 2018 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | $450,000 | $450,000 |
Earnings-call appearances
-
BridgeBio Q2 Earnings Call2026-08-10
BridgeBio Pharma, Inc. (BBIO)
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09
BridgeBio Pharma, Inc. (BBIO)
-
BridgeBio Pharma, Inc. Q1 FY2026 Earnings Call2026-05-07
BridgeBio Pharma, Inc. (BBIO)
-
TD Cowen 46th Annual Healthcare Conference2026-03-02
BridgeBio Pharma, Inc. (BBIO)
-
BridgeBio Pharma, Inc. Q4 FY2025 Earnings Call2026-02-24
BridgeBio Pharma, Inc. (BBIO)
-
8th Annual Evercore Healthcare Conference2025-12-03
BridgeBio Pharma, Inc. (BBIO)
-
BridgeBio Pharma, Inc. Q3 FY2025 Earnings Call2025-10-29
BridgeBio Pharma, Inc. (BBIO)
-
BridgeBio Pharma, Inc. Q2 FY2025 Earnings Call2025-08-05
BridgeBio Pharma, Inc. (BBIO)
-
BridgeBio Pharma, Inc. Q1 FY2025 Earnings Call2025-04-29
BridgeBio Pharma, Inc. (BBIO)